Work

Impact of Number of Prior Therapies and Bulk of Disease on Outcomes with Venetoclax (VEN) Monotherapy for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Year: 2017

Type: article

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.4329.4329

Authors: William G. Wierda, John F. Seymour, Andrew W. Roberts, Su Young Kim, L. Leanne Lash-Fleming, Johnathan C. Maher, Todd Busman, Lang Zhou, Jacqueline Nielsen, Stephan Stilgenbauer

Institutions: The University of Texas MD Anderson Cancer Center, Peter MacCallum Cancer Centre, The Royal Melbourne Hospital, AbbVie (United States), University Hospital Ulm

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2784880685

FWCI: 0.629

Cites:

Cited by: 5

Related to: 10